From the publishers of JADPRO
Metastatic Triple-Negative Breast Cancer
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge on adverse event monitoring in mTNBC
Last Updated: Monday, July 18, 2022
Fast Facts #3: Adverse Event Monitoring
Loading...
Advertisement
News & Literature Highlights
Breast Cancer: Targets and Therapy
Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective
Breast Cancer: Basic and Clinical Research
Implementation of risk-stratified breast cancer prevention with a polygenic risk score test in clinical practice
Critical Reviews in Oncology/Hematology
Advancing the PD-L1 CPS test in metastatic TNBC: Insights from pathologists and findings from a nationwide survey
Breast Cancer Research and Treatment
Investigating potential immune mechanisms of trilaciclib administered prior to chemotherapy in patients with metastatic triple-negative breast cancer
European Journal of Cancer
Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort
Expert Review of Anticancer Therapy
The role of immune checkpoint inhibition in triple negative breast cancer
Therapeutic Advances in Medical Oncology
Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: First observations from an interdisciplinary breast cancer centre in Germany
Breast Cancer: Basic and Clinical Research
Real-world survival and treatment regimens across first- to third-line treatment for advanced triple-negative breast cancer
The ASCO Post
Current management of and future possibilities for triple negative breast cancer
ESMO Open
How I Treat Metastatic Triple-Negative Breast Cancer
Advertisement
Case Studies
Treatment of a Patient With AML and mTNBC
Patient With Lung Metastasis and HER2-Low Status: Evolving Treatment Options
Fast Facts
Fast Facts #6: Immunotherapy and Endocrinopathies
Advertisement
Quizzes
Test your knowledge of treatment of patients with AML and mTNBC
Test your knowledge of evolving treatment options for patients with lung metastasis and HER2-low status
Test your knowledge on treatment and management of mTNBC